United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies
United States Molecular Diagnostics Market & Future Forecast to 2018 Overview
Molecular diagnostics is a rapidly–advancing area of research and medicine, with new technologies and applications being added continuously. Molecular diagnostics is the promising area which can transform disease diagnosis, as diagnosis based on symptoms and use of surrogate markers is replaced by genomic and proteomic analysis. This fundamental shift offers the promise for early disease detection, potentially before symptoms have even occurred.
United States molecular diagnostic market for 2018 is anticipated to more than double from its current value in 2013. In United States molecular diagnostic market, infectious disease controls the highest market share in 2013.
But in terms of test volume food pathogen testing takes the lead pushing infectious disease at number two position.
Molecular oncology tests have emerged as a significant rapidly growing market segment. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. United States constitutes the largest regional market for blood screening and blood products. Molecular diagnostics is also starting to emerge as an important tool for HLA Testing, Food Pathogen Detection Testing and other disease areas.
In companies market share Hologic Inc., Myriad Genetics and Becton Dickinson together these 3 companies control more than 50% market share for 2013. However Becton Dickinson is expected to lose its market share gradually and Roche is expected to take its place by 2018.
United States Molecular Diagnostics Market & Test Volume – Application Segment Analysis (2010 – 2018)
1. Oncology Testing
a) Breast Cancer
b) Colorectal Cancer
c) Prostate Cancer
2. Infectious Diseases
a) Virology Testing
b) HPV Testing
c) HAI Testing
d) Critical Care Testing
Renub Research study titled “United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies” provides a comprehensive assessment of the fast–evolving, high–growth Global Molecular Diagnostics Market. This 128 page report with 87 Figures studies the United States Molecular Diagnostics from 4 view points: 1) Market and Forecast 2) Application Wise Market & Forecast 3) Application Wise Test Volume & Forecast 4) Company Wise Molecular Diagnostics Sales & Forecast
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.